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INTRODUCTION
The recent advances in the establishment and
controlled differentiation of embryonic stem cells
(ESCs) have produced new model systems to access
the biology of early mammalian development includ-
ing the human development, and new approaches
to regenerative medicine (1-2) . Herein, we developed
a novel protocol for generation and selective
amplification of neural progenitor cells regionally
specified to the rostral brain from the mouse ESCs.
The neural progenitors could differentiate into
cholinergic and GABA ergic neurons both in vitro
and in vivo. Transplantation of the neural progenitors
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into the hippocampus of mouse model of traumatic
brain injury (TBI) resulted in its functional recovery
(3-6) . This could be one of the critical steps for ap-
plication of ESCs in understanding of their biology
and treatment of neurodegenerative diseases. The
identification of the mammalian neural stem cells
(NSCs) and the establishment of protocols for their
amplification and differentiation in vitro and in vivo
have brought high expectations for the clinical
application of NSCs in the cell replacement thera-
peutics to treat the damaged central nervous system
(CNS). Some studies on transplantation of in vitro
expanded neural progenitor cells (NPCs) including
NSCs and mobilization of latent NPCs in vivo in
the animal models of several neurological disorders
revealed functional recovery of the animals to some
extent (7-10) The ideal cell replacement therapeutics
using NSCs to various neurological disorders can
include replacement of specific types of neurons.
Herein, we report a novel differentiation protocol of
the mouse ESCs to generate NPCs which can generate
many functional cholinergic neurons in vitro and
in vivo(11-13) .
Neurotrophins are a family of structurally related
polypeptides that play a critical role during neuro-
nal development and appear to mediate a protective
response in mature animals. The members of the
neurotrophin family include nerve growth factor
(NGF), brain-derived neurotrophic factor (BDNF),
and fibroblast growth factor (FGF)(11-12). Neu-
rotrophins are believed to promote cell survival,
growth, and differentiation effects through interac-
tions primarily with specific high affinity tyrosine
kinase receptors and subsequent activation of the
intracellular signal transduction pathway.
In this study, we evaluated the differences in the
NSCs survival, neuronal differentiation, and spatial
memory improvement after transplantation of neu-
rospheres between mild and severe experimental
models of TBI. Moreover, much less is known
about modulation of neurotrophin expression fol-
lowing TBI. We also examined the mRNA levels of
NGF, BDNF, and FGF in the hippocampus follow-
ing mild and severe TBI.
MATERIALS AND METHODS
Animals
The experimental protocol was approved by the
Institutional Animal Care and Use Committee, and
conformed to the National Institutes of Health
(NIH) guidelines for the care and use of laboratory
animals. We used 9-week-old adult male C 57BL/6
mice weighing 20 to 22 g in all experiments.
ESC culture
Mouse ES cell lines transfected with GFP gene
were cultivated as described previously (14) . Briefly,
the cells were maintained in the absence of feeder
cells in Glasgow minimal essential medium (GMEM;
Sigma, Colorado, USA) supplemented with 10% FCS
(Equitech-Bio Inc., Kerrville, TX, USA), 1 mM
sodium pyruvate, 10-4 M 2-mercaptoethanol, 1 x non-
essential amino acids, and 1,000 U of leukemia
inhibitory factor (LIF) per ml on gelatin-coated
dishes. Then, we added 5 µg/ml of blastcydine S
(Funakoshi, Tokyo, Japan) for stem cell selection.
Differentiation of ESCs and selective amplification
and differentiation of neural progenitor cells
To induce differentiation of ESCs, a single cell
suspension of ESCs was plated onto non-adherent
bacterial culture dishes at a density of 5×104 cell/
ml in αMEM (GIBCO/Invitrogen, California, USA)
supplemented with 10% FCS, 10-4 M2-mercaptoethanol
and Noggin (inhibitor of bone morphogenic factor).
After EBs formation 6 days later , a single suspension
was obtained by trypsinization for 5 min with 0.25%
trypsin in 1mMEDTA (GIBCO/Invitrogen) , followed
by quenching with10% FCS. The cells were washed
twice with basic neurosphere medium composed of
DMEM : F 12 (1 : 1) , 0.6% glucose, 2 mM glutamine,
3 mM sodium bicarbonate, 5 mM HEPES buffer,
25 µg/ml insulin, 100 µg/ml transferring, 20 nM
progesterone, 60 µm putrescine, 30 nM selenium
chloride (all from Sigma except glutamine from
GIBCO/Invitrogen) and plated onto T 75 flasks
(Greiner, city, country) at a density of 2×104 or 1×105
cells/ml in the neurosphere medium-basic neuro-
sphere medium supplemented with 20 ng/ml FGF
2 (Peprotech, Rocky Hill, NJ, USA), 2µg/ml heparin
sulfate (Sigma) and sonic hedgehog (Shh) (15-17).
Shh is a secreted protein known to be expressed in
the notochord and floor plate, and induces ventralization
of the developing CNS (18) . The cells were grown
for 5 to 7 days and formed neurospheres. For in vitro
differentiation of NPCs, the neurospheres were plated
onto poly-L-ornithin coated dishes in the basic
neurosphere medium and cultured for 5 to 14 days.
Neurospheres were collected by settling down for
15 min and re-suspended in the neurospheres culture
medium. Cell suspensions were made at a density of
1×104cells/µl and were kept on ice to optimize the
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cell viability.
Brain Injury and Cell Transplantation
C57BL/6 mice were subjected to mild (2atm) or
severe (4 atm) lateral controlled cortical impact
brain injury (by fluid percussion). Animals were
anesthetized using a combination of ketamine (60
mg/kg body weight; Bayer, Germany) and xylazine
(20mg/kg body weight; Bayer, Germany) in saline
administered intraperitoneally. A1-cm midline scalp
incision was made and a 5-mm craniectomy was
made in the left parietal bone centered between the
coronal, sagittal, and lambdoid sutures. A hollow
plastic Luer-loc fitting was cemented into the cra-
niectomy site. The Luer-loc cap was fitted to the fluid
percussion device, and a lateral fluid percussion
injury of mild (2atm) or severe (4atm) severity was
delivered by a rapid percussion? of saline that struck
the exposed dura mater through the sealed fitting
(40 animals) . After the injury, the capswere removed
and the scalps were sutured. Eight animals (control
group) were subjected to the same anesthesia and
surgical procedures but without TBI (2, 3, 9).
On day 7 post-injury, all animals were anesthe-
tized with intraperitoneal injection of 60 mg/kg
sodium pentobarbital and placed in a stereotactic
frame. In the animals assigned to receive trans-
plants, separate injections of 2 ul of cell suspension
(a total 1×106 cells/brain) were stereotactically
delivered through a 10-ul Hamilton syringe into each
injured site by using the following coordinates cal-
culated from the bregma (A and L) and dura mater
(V) according to the atlas of Paxinos and Watson :
A=2.5 mm, L=2.5 mm, V=2 mm. In all animals that
received injections of cells or vehicle, the syringe
was slowly advanced through the dura mater and
cortex. The cell suspension was injected over 10
min into the injured site. The needle was left in
place for 5 min, and then gradually withdrawn over
5 min. The injured animals and uninjured controls
were subjected to similar procedures and injection
of vehicle to control the effects of cannula microin-
jection.
Behavioral Assessment
Eight-direction maze test was initiated 8 weeks
after transplantation and conducted as described
elsewhere (19). The radial maze consisted of 8 sym-
metrical arms (25cm long, and 6cm wide, with side
walls 6 cm high), radiating from an octagonal
central platform (10.5cm in diameter) . The platform
was enclosed by a wall (6cm high) . The floor of the
maze was made of wood painted white, and the wall
consisted of transparent Plexiglas. The apparatus
was elevated 50 cm above the floor and placed in a
closed roomwhere all visual cueswere kept unchanged
throughout the test trial. During the experiment,
the maze was maintained in a constant orientation,
and the investigator stayed in a constant position
beside the maze and observed the performances
of the mice. Completion of the radial maze entailed
mouse running down and retrieving a food pellet
of 15 mg at the end of each arm. An arm entry was
defined as crossing of the four paws into an arm.
Before each session of the test, the mice were
deprived of food until their body weight was reduced
to 80-85% of the initial level. Pretraining started three
days before the test, in which each animal was
placed in the central platform and allowed to
explore and consume a food pellet at the end of
each arm. This was repeated daily for three con-
secutive sessions. During the test trail (3 weeks),
only 4 arms were baited with food pellets, and each
mouse was given one daily trail for 6 days/week.
For each trial, two parameters ; namely, reference
memory error (entry into the unbaited arms) and
working memory error (repeated entry into the arms
that had already been visited within a trial), were
measured.
Histology and Immunohistochemistry
One week after completion of the behavioral testing
(12 weeks after transplantation) , all mice were deeply
anesthetized with ketamine and xylazine and perfused
transcardially with saline for 3 min and then with
ice-cold 4% paraformaldehyde (PFA) in 0.1 M PBS
(pH 7.4) for 30min. Then, the brains were removed
and placed in paraformaldehyde? (PFA) overnight.
Then, 30-µm thick coronal or sagittal sections were
cut on a vibratome (D. S. K microslicer, Japan) into
series and placed free floating in PBS at 4. The
primary antibodies (final dilution and source) used
in this study were as follows : rabbit polyclonal anti-
human choline acetyl transferase (ChAT) (1 : 200 ;
Chemicon, Temecula, CA, USA), rabbit polyclonal
anti-humanβ -III-tubulin (1:200;DAKO, Carpinteria,
CA, USA) , rabbit polyclonal anti-feline glutamic acid
decarboxylase (GAD67) (1:200;Chemicon) , mouse
monoclonal anti-human GFAP IgG (1:100, Sigma) ,
rabbit polyclonal anti-human glial fibrillary acidic
protein (GFAP) IgG (1:200;DAKO) , rabbit polyclonal
anti-green fluorescence protein (GFP) (1 : 1000 ;
MBL, Nagoya, Japan), mouse monoclonal anti-
GFP (Molecular Probes, Eugene, OR, USA), mouse
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monoclonal anti-Hu C/D (Molecular Probes) . Guinea
pig polyclonal antibodies to VAChT (1µg/ml) were
raised against amino acid residues 472-530 of mouse
VAChT (GenBank, AF 019045) as described previously
(20). The specificity of the VAChT antibodies was
confirmed by the Western blotting analysis of adult
mouse brain. Goat polyclonal anti-mouse, rabbit and
guinea pig IgG conjugated with Alexa 350,488 and
568(Molecular Probes) were used as secondary
antibodies. For immuno-labeling, fluorescent signals
were amplified using TSATM fluorescein system
(Perkin Elmer Life Science, Boston, MA, USA)
using biotinylated secondary antibodies according
to the manufacturer's protocol.
For the in vitro studies, cells on coverslips were
fixed with 4% PFA in PBS in the presence or absence
of 0.1% gluteraldehyde and processed for indirect
immunocytochemistry. For the in vivo studies, mice
were killed by anesthetic overdose and perfused
transcardially with 4% PFA in PBS in the presence
or absence of 0.1%gluteraldehyde. The brains were
post-fixed in the perfusion solution for 2-12 hr at 4.
Free-floating sections from the brains were prepared
as 40-µm coronal cryosections (-20) using a mi-
croslicer (DTK-2000, Dosaka EM, Osaka, Japan).
The sections were rinsed with 0.1% Triton X-100/
PBS, then incubated for 24 hr (4) in the primary
antibody diluted in 10% normal goat serum /PBS.
After incubation in the primary antibody, the sec-
tions were washed and incubated with the regular
secondary antibodies for 2 hr or with the bioti-
nylated secondary antibodies 1 hr at room tem-
perature. Fluorescent signals were detected and
analyzed using a fluorescence microscope(Axio-
Photo 2 ; manufacturer, city, country)and a confocal
laser scanning microscope (LSM 510 ; Zeiss, Jena,
Germany).
Reverse Transcription-Polymerase Chain Reaction
(RT-PCR) Analysis
The hippocampus tissue was collected under a
stereotactic microscope. RNA was extracted from
the frozen tissue sample by using ISOGEN reagent
(Nippon Gene, Toyama, Japan). Briefly, 10 mg of
tissue were homogenized in 0.5 ml of ISOGEN.
Subsequently, 0.1 ml of chloroform was added and
the mix was centrifuged. This separated the solution
into an aqueous phase containing RNA, an interphase
containing DNA, and an organic phase containing
protein. The aqueous layer was aspirated and added
to 0.5ml of isopropanol for RNA precipitation. Next,
the solutionwas centrifuged and the pellet was washed
with 70% ethanol and centrifuged. Subsequently,
RNA was collected into 50 µl of diethylpyrocarbon-
ate (DEPC) -treated water. RT-PCR was done using
a First-Strand cDNA Synthesis Kit (Amersham
Pharmacia Biotech Limited, Buckinghamshire, UK).
Two microliters of total RNA (2 µg) were added to
5.5 µl of the RT mixture. After mixing, the samples
were incubated at 37 for 45 min, 95 for 5 min,
and 4 for at least 5 min. Then, 17.5 µl of PCR-
mixture containing 12.5 µl primers and Taq DNA
polymerase (Amersham Pharmacia Biotech Limited)
were added to the RT products. Initial denaturation
for 2min at 94 was followed by 30 cycles of 1min
at 94, 1min at 55, and 2min at 72, and a final
extension for 6 min at 72. The PCR products
were separated on 2% agarose gels, and ethidium
bromide-stained bands were recorded by Mupid-2
R (Cosmo-Bio, Tokyo, Japan) . The primer sequences
were as follows :
NGF : forward primer : 5’primer : 5’-
TAAAAAGCGGCGACTCCGTT-3’, reverse primer:5’-
ATTCGCCCCTGTGGAAGATG-3’.








ββ-actin : forward primer : 5’primer : 5’-
ATCACCATTGGCAATGAGGG-3’,reverse primer:5’-
TTGAAGGTAGTTTCGTGGAT-3’.
The percentages of NGF, BDNF,
and FGF-2 mRNA/β-actin
mRNA were assessed by NIH software using computer.
Statistical Analysis
The behavioral scores were analyzed using one-
way analysis of variance (ANOVA) and the Student’s
t-test. P values of less than 0.05 were considered
significant. The values in the graphs are expressed
as mean±SEM. The Student’s t-test was used to
evaluate the relationships among various neu-
rotrophins mRNA expression. The differences in
the percentages of NGF mRNA/β-actin mRNA,
BDNF mRNA/β-actin mRNA, and FGF-2 mRNA/
β-actin mRNA were assessed, using the StatView
software for windows.
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RESULTS
Derivation and selective amplification of neural
progenitor cells from embryonic stem cells
Clonally derived sphereswere allowed to differentiate
on the adhesive substrate in the absence of mitogen
for five days followed by β-III-tubulin (neurons),
GFAP (astrocytes) and O4 (oligodendrocytes) im-
munocytochemistry. Virtually, all the clones were
neuronal but no sign of glial differentiation (Fig.1a)
(Fig.1b:positive control for β-III-tubulin:red, GFAP:
blue, and O4:green) . To further characterize the ES-
derived NPCs, we analyzed the neurotransmitter
phenotypes of the differentiated neurons from the
neurospheres. As shown in Fig.1c, most of the neurons
that differentiated from neurospheres were ChAT-
immunoreactive (green) cholinergic neurons in Hu
C/D+ (red) neuron. GAD67-immunoreactiveGABAergic
or GFAP+ astrocytes were barely observed (data
not shown) in the neurons derived from the neuro-
spheres.
Neurospheres survival and differentiation mainly
into cholinergic neurons after transplantation into
the cortex
At 12 weeks (a week after the behavioral test)
post-injury, surviving grafts could be identified in
all mild TBI animals that received transplantation
of neurospheres. Initial evaluation of the graft survival
was conducted using eGFP-stained sections. None-
theless, no surviving grafts could be identified in
the severe TBI mice that received transplantation
of neurospheres. To know whether the grafted ES-
derived NPCs generated cholinergic neurons, we
carried out immunohistochemical analysis of the
brains of the transplanted mice. We found significant
cholinergic differentiation recognized as ChAT im-
munoreactivity in the eGFP+ transplanted cells in
the mild TBI mice (Fig.2a, b, c). Moreover, the grafts
contained little amount of GAD 67+cells (Fig.2
d, e, f). However, we barely found GFAP+ astrocytes
within the grafts (Fig.2 g, h, i). Furthermore, pre-
Fig 1. Immunocytochemistry of differenti-
ated progeny of ES-derived NPCs.
Neurospheres (a) and positive control (b) were
differentiated as described in the text. Scale
bars = 50 µm. Triple labeling (β-III-tubulin :
red, GFAP : blue, and O4 : green) immuno-
cytochemistry showed unipotent neuronal
differentiation of clonally derived and mul-
tipotent (neurons and glia) differentiation of
positive control neurospheres. c) Differen-
tiation of neurospheres into ChAT+ green)
expressions in HuC/D+ (red) neurons.
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synaptic formations of graft-derived neurons were
recognized by immunohistochemistry of vesicular
acetylcholine transporter (VAChT) which is spe-
cifically expressed on the axons of the cholinergic
neurons, near the grafts around CA 3 (Fig.2 j, eGFP ;
green, VAChT ; red).
mRNA Expression of neurotrophins
We examined NGF, BDNF, and FGF-2 mRNA
by RT-PCR from 12 mouse including normal, mild
TBI and severe TBI groups. Increases in the
neurotrophic factors mRNA were evident in the
hippocampus on the ipsilateral side in the mild
TBI group. Statistical analysis revealed significant
differences between the mild and severe TBI groups.
The data also revealed significant differences be-
tween the mild TBI and normal groups (Fig. 3).
The percentages of NGF, BDNF, and FGF-2
mRNA/β-actin mRNA were significantly higher in
the mild TBI group (68.2±15.3%, 94.7±45.6%, 48.4
±15.4%)than in the severe TBI group (5.4±2.2%,
2.8±1.5%,1.8±1.9% ; p<0.01, p<0.01, p<0.01). The
percentages of NGF, BDNF, and FGF-2 mRNA/β-
actin mRNA were significantly higher in the mild
Fig 2. Differentiation of ES-derived NPCs in the hippocampus of the
brain-injured mice.
Confocal images of fluorescent immunohistochemistry obtained from the
mice killed 12 weeks after transplantation. Scale bars=50 µm. (a, b, c) A
three-dimensional confocal image showing GFP+ (green)/ChAT+ (red)
cells, indicating neuronal differentiation. (d, e, f) Differentiation of GAD 67
-expressing GABAergic neurons was barely observed. (g, h, i) Differentia-
tion of GFAP-expressing astrocytes was barely observed. (j) Confocal
images of VAChT immunohistochemistry showing presynaptic formations
of cholinergic neurons derived from the grafted NPCs around CA 3.
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TBI group than in the normal group (21.5±8.3%,
18.3±7.8%, 13.5±6.2% ; p<0.05, p<0.05, p<0.05).
Eight-arm radial maze testing
The mild TBI animals that received transplantation
of neurospheres showed significantly improved learn-
ing ability as compared with the severe TBI animals
and no transplantation of neurospheres. Fig. 4 shows
the mean scores of working memory errors and
reference memory errors on the eight-arm radial
maze performance in all 5 groups of mice, with data
averaged from 18 trials. In the NBM-lesioned mice,
the working memory errors increased signifi-
cantly (t=6.13, p<0.001 vs. the control group). In
the mice transplanted with neurospheres, the scores
were restored (t=0.307, p<0.05, vs. the control group).
With respect to the scores of mice in the non-
treated group with NPC transplants, the working
memory deteriorated remarkably (t=5.95, p<0.001
vs. the normal group; t=6.46, p<0.001 vs. the NBM-
lesioned group). There were no differences in the
working memory errors between the NPC trans-
plants group and non-treated group in the severe
TBI (p>0.05).
DISCUSSION
One of major the findings in this study is that
ES-derived NPCs exhibited similar differentiation
potential both in vitro and in vivo . This is in
contrast to the study by Wu et al. (21) who found”
primed” human neural progenitors capable of
generating multiple types of neurons including
cholinergic neurons in vitro differentiated into neu-
rons specific to the site of transplantation in the
adult rat CNS. For example, the primed human
NPCs generated only GABAergic neurons in the adult
hippocampus (1) . In our present study, however,
NPCs derived from mouse ESCs transplanted into
the adult hippocampus generated many cholinergic
and a few of GABAergic neurons but rarely astrocytes,
like their in vitro differentiation. Strikingly, inner-
vations of the graft-derived cholinergic axons into
CA 3 regions which are the target sites of the septal
cholinergic projections, synaptic formations and
functional recovery from the TBI-induced learning
Fig.3. mRNA Expression of neurotrophins.
We examined the expressions of NGF, BDNF, and FGF-2
mRNA by RT-PCR from 12 mice including normal, mild TBI
and severe TBI groups. Increases in the neurotrophic factors
mRNA were evident in the hippocampus on the ipsilateral side
in the mild TBI group. Statistical analysis revealed significant
differences between the mild and severe TBI groups. The data
also revealed significant differences between the mild TBI and
normal groups. The percentages of NGF, BDNF, and FGF-2
mRNA/β-actin mRNA were significantly higher in the mild TBI
group (68.2±15.3 %, 94.7±45.6 %, 48.4±15.4 %) than in the
severe TBI group (5.4±2.2 %, 2.8±1.5 %, 1.8±1.9 % ; p<0.01, p
<0.01, p<0.01). The percentages of NGF, BDNF, and FGF-2
mRNA/β-actin mRNA were significantly higher in the mild TBI
group than in the normal group (21.5±8.3 %, 18.3±7.8 %, 13.5
±6.2 % ; p<0.05, p<0.05, p<0.05).
Fig.4. Effects of neurospheres and ESCs on the eight-arm
radial maze performance of mice.
The mild TBI animals that received transplantation of neuro-
spheres showed significantly improved learning ability as com-
pared with the severe TBI animals and no transplantation of
neurospheres. The mean scores of the working memory errors
and reference memory errors on the 8-arm radial maze per-
formance of all 6 groups of mice are shown, with data averaged
from 18 trials. With respect to the scores of mice in the no-
treatment group with NPC transplants, the working memory of
TBI group mice deteriorated remarkably (＊1, ＊2 : t=5.95, p<
0.001 vs. normal group ; t =6.46, p<0.001 vs the TBI group). In
the mild TBI group mice transplanted with neurospheres, the
scores were restored (＊3 : t=0.307, p>0.05, vs. the NPC group).
There were no differences in the working memory errors be-
tween NPC transplants group and no-treatment group in severe
TBI (#4 : p>0.05, F=0.1439, d. f. = 4.62)
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and memory deficits were observed. Thus, the ESCs
can be excellent source for production of functional
cholinergic neurons. However, we could not exclude
the possibility that trophic effects from the grafts
enhanced the function of the remaining septal
cholinergic neurons and ameliorated the deficits.
Another important finding is that the neurosphere
-transplanted animals with mild TBI survived in
the hippocampus (CA 3). At 12 weeks after trans-
plantation (a week after the behavioral test) , we found
significant cholinergic differentiation recognized
as ChAT immunoreactivity in the eGFP+ trans-
planted cells. Moreover, the grafts contained few
GAD 67+cells. However, we barely found GFAP+
astrocytes within the grafts (Fig. 2) . Moreover, pre-
synaptic formations of graft-derived neurons were
recognized by VAChT immunohistochemistry which
is specifically expressed on the axons of the cholinergic
neurons, near the grafts around CA 3 (Fig.3).
However, these findings were not observed in the
severe TBI group. These results might be due to
differences in the microenvironment between the mild
and severe TBI groups. So, we examinedNGF,BDNF,
and FGF-2 mRNA by RT-PCR from 12 mice
including normal, mild TBI and severe TBI groups.
Increases in the neurotrophic factors mRNA were
evident in the hippocampus on the ipsilateral side
in the mild TBI group. Statistical analysis revealed
significant differences between the mild and severe
TBI groups. The data also revealed significant dif-
ferences between the mild TBI and normal groups
(Fig. 3). The percentages of NGF, BDNF, and
FGF-2 mRNA/β-actin mRNA were significantly
higher in the mild TBI group than in the severe
TBI group. The percentages of NGF, BDNF, and
FGF-2mRNA/β-actin mRNA were significantly higher
in the mild TBI group than in the normal group.
Most of the surviving grafts in CA3 differentiated into
cholinergic neurons. A few cells around the surviving
grafts in CA 3 differentiated into GABAergic neurons.
The surviving grafts might promote differentiation
of the cells around them into GABAergic neurons.
It has been reported that transplantation of BDNF
promoted differentiation into neurons after TBI
(22) . Accordingly, BDNF might activate the NSCs
and then lead to differentiation of NSCs into neurons.
Hicks et al. noticed a moderate increase in BDNF
mRNA expression in CA3 region of the hippocam-
pus up to 12 hr post-injury and then remained above
the control levels for 72 hr post-injury after mild
FP injury (23) . A significant increase in BDNF mRNA
expression was observed in CA 3 region and then
remained above the control levels after severe FP
injury. Nonetheless, they did notice BDNF mRNA
expression after 7 days post-injury. Our study showed
that the transplanted neurosphere survived in the
mild TBI animals, but not in the severe TBI group.
These findings might correlate with the absence
of neurotrophic factors in the hippocampus of the
severe TBI animals. Several previous studies on
ES cell transplantation examined the functional recovery
following injury. It has been showed that minced
fetal cortical grafts (E16) implanted after TBI in the
rat significantly improved the neuromotor function
and cognitive function in MWM as compared to rats
injected with saline (5, 24). Significant improve-
ments in the cognitive performance and neuromotor
function were demonstrated with immortalized neural
progenitors derived from the embryonic rat hip-
pocampus (HIB5) , that were subsequently transfected
to secrete NGF transplanted into the traumatically
injured rat brain (1) . It has also been shown that
transplantation of NT 2 N human neuronal cells
transfected to secrete NGF can improve the cognitive
function when transplanted into the striatum of
brain-injured mice (25). On the contrary, trans-
plantation of neuronal and glial precursors reportedly
improves the sensorimotor function dramatically
but not the cognitive function in the traumatically
injured brain (26) . The latter investigators stated
that the ESCs migrating to the hippocampus or
striatum might have produced significant improve-
ments in the cognitive function if testing was delayed
for another couple of months. Thus, the improve-
ments in the cognitive function following injury in
the present study are consistent with the findings
in other transplantation studies.
An involvement of the basal forebrain cholinergic
system in the cognitive functions is evident. Nu-
merous studies analyzed the functional roles of the
basal forebrain cholinergic neurons and indicated
their contribution to the learning and memory
functions ; supporting the cholinergic hypothesis
of memory dysfunction in the aged and Alzheimer’s
disease (AD) patients, since loss of basal the forebrain
cholinergic neurons or acetylcholine synthesis is
often observed in the brains of patients with advanced
dementia (27, 28). On the other hand, however, recent
sensitive and reliable neurological analyses of AD
patients in the early stages suggest that the cholin-
ergic deficit occurs only in the late stage of the
disease (29). The in vitro generation of functioning
cholinergic neurons and their precursors presented
here should facilitate the development of efficient
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systems for drug development and screening. For
further understanding of those diseases and devel-
opment of medications, application of our system
into the human ESCs, which provides another access
to the biology of the human cholinergic neurons,
could be an important step.
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